Epigenetic Changes and Functions in Pneumoconiosis.

Area of Science:

• Occupational Medicine
• Pulmonary Medicine
• Epigenetics

Background:

• Pneumoconiosis is a prevalent occupational disease with significant socioeconomic impact.
• Lack of specific treatments for pneumoconiosis necessitates understanding its pathogenesis.
• Pulmonary fibrosis, a common feature in pneumoconiosis, COVID-19, and idiopathic pulmonary fibrosis, involves excessive extracellular matrix deposition and tissue remodeling.

Purpose of the Study:

• To elucidate the role of epigenetic factors in the pathogenesis of pneumoconiosis.
• To identify potential therapeutic targets for pneumoconiosis and related fibrotic lung diseases.

Main Methods:

• Review of epidemiological investigations, in vivo, and in vitro experimental evidence.
• Analysis of epigenetic changes (DNA methylation, noncoding RNA) in key lung cells (macrophages, fibroblasts, alveolar epithelial cells).

Main Results:

• Epigenetic alterations are integral to the occurrence and progression of pneumoconiosis.
• Specific epigenetic mechanisms can either promote or inhibit pneumoconiosis development.
• Evidence highlights the involvement of macrophages, fibroblasts, and alveolar epithelial cells in these epigenetic processes.

Conclusions:

• Epigenetic modifications are crucial in pneumoconiosis pathogenesis.
• Understanding these epigenetic changes provides insights for developing targeted therapies for pneumoconiosis.
• Findings may also inform treatment strategies for other pulmonary fibrosis conditions.